Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Định dạng: PDF / Số trang: 7

Nhắn tin với admin nếu không tải được